Skip to main content

SB 1724 — Missouri

Makes xylazine a Schedule III controlled substance

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

SB 1724 - This act makes xylazine a Schedule III controlled substance, except for certain uses described in the act, including manufacturing a drug for an animal or administering the drug to an animal.

This act is substantially similar to HB 1881 (2026).
SARAH HASKINS

Official abstract, as published by the legislature.

  • SB 1724 is a bill in the Missouri Senate, 2026 session, introduced February 25, 2026.
  • Sponsored by Justin Brown.
  • Current status: introduced.
  • Most recent action (May 7, 2026): Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee.
  • Subjects: Animals, Drugs and Controlled Substances, Pharmacy, Veterinarians.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Justin Brown

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate S First Read
  2. Senate Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee Latest

Source: Open States. Last checked November 4, 2026. How we keep this accurate ›